Congratulations to the finalists of the 2024 Fierce Life Sciences Innovation Awards below!
All of the entries were judged on the ability of the applicant to demonstrate the following: effectiveness, technical innovation, competitive advantage, financial impact, and true innovation.
The winners will be announced in the Innovation Report on Monday, December 2nd, which will feature spotlights and interviews of all category winners.
AI Innovation
BostonGene: AI-based pathology
Apollo Intelligence: Apollo Intelligence Next-Generation Platform for Market Insights
Etcembly Ltd: EMLy
Genialis: Genialis™ krasID
Biotech Innovation
Coya Therapeutics: Coya Therapeutics, COYA 302
Stablepharma Ltd: Fridge-free Vaccine & Pharmaceutical Technology
NeuroKaire: NeuroKaire
Verona Pharma: Ohtuvayre (ensifentrine)
Data Analytics/Business Intelligence
EncompaaS: EncompaaS Rebate Management
BostonGene: Patient timeline from unstructured data
DNAnexus: The DNAnexus-built Research Analysis Platform for UK Biobank
Truveta: Truveta Language Model
Digital Health Solutions
juli Inc: juli
Acclinate: NOWINCLUDED Powered by Acclinate
Viz.ai, Inc.: Viz HCM™
iRhythm Technologies Inc.: Zio® ECG monitoring service
Drug Delivery Technology
Regeneron: Retargeted Antibody AAV Platform
COUR Pharmaceuticals: COUR Nanoparticle Platform
Enable Injections: enFuse Wearable Drug Delivery System
Belhaven Biopharma: Nasdepi
Medical Device Innovation
Medtronic: MiniMed 780G system
RefleXion Medical: RefleXion® X1 with SCINTIX® biology-guided radiotherapy
MMI (Medical Microinstruments): Symani Surgical System
Tandem Diabetes Care: Tandem Mobi
Terran Biosciences: Terran Biosciences’ NM-101
Vibrant Gastro: Vibrant
Technology Innovation
BenchSci: ASCEND
Cellares: Cellares Cell Shuttle + Cell Q
Luminopia Inc.: Luminopia
Ocutrx Technologies, Inc.: OcuLenz AR for individuals with AMD